Get the Weekly Intelligence Brief — top committee picks every Sunday.

ABT vs LLY

Abbott Laboratories vs Eli Lilly and Company — AI-powered side-by-side comparison
ABT
Abbott Laboratories
66
Buy
VS
LLY
Eli Lilly and Company
56
Buy
MetricABTLLY
AI Score 66 56
Price $115.88 $1,238.69
P/E Ratio 37.51× 41.81×
ROE 12.5% 77.8%
Revenue Growth YoY
Gross Margin 56.8% 84.0%
Debt / Equity 0.64× 1.62×
Dividend Yield 2.1% 0.5%
RSI (14) 84.7 59.0
Beta 0.581 0.506
Expected Upside +0.1% +0.1%

AI Committee View

Current Innellis committee reasoning for ABT versus LLY.
ABT leads by 10 points.

ABT scores 66/100 (Buy) versus LLY at 56/100 (Buy).

ABT Committee View
50% agreement
4 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • RSI at 85 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • Weekly RSI at 83 -- overbought on the larger timeframe too — Technical
LLY Committee View
67% agreement
6 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 49.6% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 1.60) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 92.6% shows genuine earnings power backing the valuation — Value
  • Revenue growing 49.6% YoY -- genuine top-line momentum — Growth
  • EPS growing 94.6% YoY — Growth
Bear Case
  • P/E of 43.2 is expensive by classic value standards — Value
  • Price-to-book of 38.3x prices in significant intangible value — Value
  • Debt-to-equity of 1.60 adds balance-sheet risk to the value case — Value
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABT Full Analysis LLY Full Analysis